检索结果 - David W. Cescon

Refine Results
  1. 1
    <i>APOBEC3B</i>expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation

    <i>APOBEC3B</i>expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation 由 David W. Cescon, Benjamin Haibe‐Kains, Tak W. Mak

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Seize the engine: Emerging cell cycle targets in breast cancer

    Seize the engine: Emerging cell cycle targets in breast cancer 由 Jesús Fuentes‐Antrás, Philippe L. Bédard, David W. Cescon

    出版 2024
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Evolution of the Randomized Controlled Trial in Oncology Over Three Decades

    Evolution of the Randomized Controlled Trial in Oncology Over Three Decades 由 Christopher M. Booth, David W. Cescon, Lisa Wang, Ian F. Tannock, Monika K. Krzyzanowska

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis

    Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis 由 Hadar Goldvaser, T. Barnes, Boštjan Šeruga, David W. Cescon, Alberto Ocaña, Domen Ribnikar, Eitan Amir

    出版 2017
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Invasive Pulmonary Aspergillosis Associated With Marijuana Use in a Man With Colorectal Cancer

    Invasive Pulmonary Aspergillosis Associated With Marijuana Use in a Man With Colorectal Cancer 由 David W. Cescon, Andrea Page, Susan E. Richardson, Malcolm J. Moore, Scott Boerner, Wayne L. Gold

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Extended Adjuvant Tamoxifen for Early Breast Cancer: A Meta-Analysis

    Extended Adjuvant Tamoxifen for Early Breast Cancer: A Meta-Analysis 由 Mustafa Al-Mubarak, Ariadna Tibau, Arnoud J. Templeton, David W. Cescon, Alberto Ocaña, Boštjan Šeruga, Eitan Amir

    出版 2014
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  7. 7
    Changes in circulating tumor DNA and outcomes in solid tumors treated with immune checkpoint inhibitors: a systematic review

    Changes in circulating tumor DNA and outcomes in solid tumors treated with immune checkpoint inhibitors: a systematic review 由 Laith Al-Showbaki, Brooke E. Wilson, Faris Tamimi, Consolación Moltó, Abhenil Mittal, David W. Cescon, Eitan Amir

    出版 2023
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  8. 8
    NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma

    NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma 由 David W. Cescon, Desmond She, Shingo Sakashita, Chang‐Qi Zhu, Melania Pintilie, Frances A. Shepherd, Ming‐Sound Tsao

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Ionizable Drugs Enable Intracellular Delivery of Co‐Formulated siRNA

    Ionizable Drugs Enable Intracellular Delivery of Co‐Formulated siRNA 由 Kai V. Slaughter, Eric N. Donders, Michael S. Jones, Sami G. Sabbah, Mitchell J. Elliott, Brian K. Shoichet, David W. Cescon, Molly S. Shoichet

    出版 2024
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Gene isoforms as expression-based biomarkers predictive of drug response in vitro

    Gene isoforms as expression-based biomarkers predictive of drug response in vitro 由 Zhaleh Safikhani, Petr Smirnov, Kelsie L. Thu, Jennifer Silvester, Nehmé El-Hachem, Rene Quevedo, Mathieu Lupien, Tak W. Mak, David W. Cescon, Benjamin Haibe‐Kains

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster influences phenotypic expression of Crohn’s disease

    A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster influences phenotypic expression of Crohn’s disease 由 William G. Newman, Xiangjun Gu, Richard F. Wintle, David W. Cescon, Mehrdad Yazdanpanah, Xiangdong Liu, Vanya Peltekova, Mark Van Oene, Christopher I. Amos, Katherine A. Siminovitch

    出版 2005
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

    Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts 由 Arvind Singh Mer, Wail Ba-Alawi, Petr Smirnov, Yi X. Wang, Ben Brew, Janosch Ortmann, Ming‐Sound Tsao, David W. Cescon, Anna Goldenberg, Benjamin Haibe‐Kains

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review

    Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review 由 Jessica Hopkins, David W. Cescon, Darren Tse, Penelope A. Bradbury, Wei Xu, Clement Ma, Paul Wheatley‐Price, John Waldron, David P. Goldstein, François Meyer, Isabelle Bairati, Geoffrey Liu

    出版 2008
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  14. 14
    TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancer

    TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancer 由 Rebecca Dent, David W. Cescon, Thomas Bachelot, Kyung Hae Jung, Zhi‐Ming Shao, Shigehira Saji, Tiffany A. Traina, Petra Vuković, Darlington Mapiye, Micah J. Maxwell, Peter Schmid, Javier Cortés

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Functional Characterization of CFI-400945, a Polo-like Kinase 4 Inhibitor, as a Potential Anticancer Agent

    Functional Characterization of CFI-400945, a Polo-like Kinase 4 Inhibitor, as a Potential Anticancer Agent 由 Jacqueline M. Mason, Dan Lin, Wei Xin, Yi Che, Yi Yao, Reza Kiarash, David W. Cescon, Graham C. Fletcher, Donald E. Awrey, Mark R. Bray, Guohua Pan, Tak W. Mak

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer

    Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer 由 Kelsie L. Thu, Jennifer Silvester, Mitchell J. Elliott, Wail Ba-Alawi, Meghan Duncan, Andrea C. Elia, Arvind Singh Mer, Petr Smirnov, Zhaleh Safikhani, Benjamin Haibe‐Kains, Tak W. Mak, David W. Cescon

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic Lethality

    Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic Lethality 由 Peter Lin, Corey Lourenco, Jennifer Cruickshank, Luís Palomero, Jenna E. van Leeuwen, Amy H.Y. Tong, Katherine Chan, Samah El Ghamrasni, Miguel Ángel Pujana, David W. Cescon, Jason Moffat, Linda Z. Penn

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer

    TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperabl... 由 Peter Schmid, Mafalda Oliveira, Joyce O’Shaughnessy, Massimo Cristofanilli, Stephanie L. Graff, Seock-Ah Im, Sherene Loi, Shigehira Saji, Shusen Wang, David W. Cescon, Tina Hovey, Agata Nawrot, KY Tse, Petra Vuković, Giuseppe Curigliano

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Functional variants of OCTN cation transporter genes are associated with Crohn disease

    Functional variants of OCTN cation transporter genes are associated with Crohn disease 由 Vanya Peltekova, Richard F. Wintle, Laurence A. Rubin, Christopher I. Amos, Qiqing Huang, Xiangjun Gu, William G. Newman, Mark Van Oene, David W. Cescon, Gordon R. Greenberg, Anne M. Griffiths, Peter St George‐Hyslop, Katherine A. Siminovitch

    出版 2004
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Relationship between tumor infiltrating lymphocyte (TIL) levels and response to pembrolizumab (pembro) in metastatic triple-negative breast cancer (mTNBC): Results from KEYNOTE-086

    Relationship between tumor infiltrating lymphocyte (TIL) levels and response to pembrolizumab (pembro) in metastatic triple-negative breast cancer (mTNBC): Results from KEYNOTE-086 由 Sherene Loi, Sylvia Adams, Peter Schmid, Javier Cortés, David W. Cescon, Eric P. Winer, Deborah Toppmeyer, Hope S. Rugo, Michelino De Laurentiis, Rita Nanda, Hiroji Iwata, Ahmad Awada, Antoinette R. Tan, A. Wang, Gursel Aktan, Vassiliki Karantza, Roberto Salgado

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: